Robert J. Lefkowitz

Robert J. Lefkowitz

James B. Duke Professor of Medicine, Biochemistry, Chemistry; HHMI, Duke University
在 receptor-biol.duke.edu 的电子邮件经过验证
被引用次数：206451
GPCRs Structural biology Biochemistry Arrestins Drug discovery
Marc G. Caron

Marc G. Caron

James B. Duke Professor, Cell Biology, Medicine, Neurobiology Duke University
在 duke.edu 的电子邮件经过验证
被引用次数：146312
GPCR Signaling Psychiatric Disorders Addiction Drug Discovery
Paul I W de Bakker

Paul IW de Bakker

Vertex Pharmaceuticals
在 vrtx.com 的电子邮件经过验证
被引用次数：130192
human genetics computational genomics structural biology drug discovery bioinformatics
Michael P. Lisanti, MD-PhD, FRSA, FRSB, FRSC

Michael P. Lisanti, MD-PhD, FRSA, FRSB, FRSC

Professor and Chair of Translational Medicine, University of Salford (Greater Manchester)
在 salford.ac.uk 的电子邮件经过验证
被引用次数：119485
Senescence Mitochondria Cancer Stem Cells Breast Cancer Drug Discovery
Ashish Awasthi

Ashish Awasthi

CSIR-Central Drug Research Institute (CDRI)
在 cdri.res.in 的电子邮件经过验证
被引用次数：105464
Biostatistics Public Health Drug Discovery
Wei Li

Wei Li

University of Tennessee Health Science Center
在 uthsc.edu 的电子邮件经过验证
被引用次数：91828
drug discovery medicinal chemistry cancer neurodegenerative diseases analytical chemistry including NMR UPLC …
Philip E. Bourne

Philip E. Bourne

University of Virginia
在 virginia.edu 的电子邮件经过验证
被引用次数：88439
Data Science Computational Biology Drug Discovery Scholarly Communication Professional
Oliver Kepp

Oliver Kepp

INSERM UMR1138 / Gustave Roussy Cancer Center
在 gustaveroussy.fr 的电子邮件经过验证
被引用次数：77702
Anticancer immunotherapy Drug discovery
Tom L Blundell

Tom L Blundell

Emeritus Professor of Biochemistry, University of Cambridge
在 cam.ac.uk 的电子邮件经过验证
被引用次数：76804
Structural biology Bioinformatics Biochemistry Drug Discovery
James Bradner

James Bradner

Novartis Institutes for BioMedical Research
在 novartis.com 的电子邮件经过验证
被引用次数：69169
Chemical Biology Chromatin Biology Cancer Biology Targeted Protein Degradation Drug Discovery
1 - 10